The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn MoreAs Seen in nocamels.com
Modern medicine allows people to live longer and better, but with these life-enhancing therapies comes a risk of what clinicians call an adverse drug reaction (ADR) and laymen know as side effects.
This is especially the case with polypharmacy (when patients take five or more drugs at the same time), says Liat Primor, veteran of the pharmaceutical industry and CEO and co-founder of FeelBetter (opens in a new tab), a startup dedicated to improving outcomes for patients taking multiple medications.
“Sometimes patients have not only one condition, they have plenty – 10 or 15 – and they take so many medications,” Primor tells NoCamels.
“They call them the yellow pills, the blue pills, the purple pills,” she says. “They don’t even know that they have a ‘bad pill.’”
FeelBetter Co-founders CEO Liat Primor and CTO and COO Yoram Hordan are Technion alumni.